Page last updated: 2024-09-03

nnc 112 and mdl 100907

nnc 112 has been researched along with mdl 100907 in 1 studies

Compound Research Comparison

Studies
(nnc 112)
Trials
(nnc 112)
Recent Studies (post-2010)
(nnc 112)
Studies
(mdl 100907)
Trials
(mdl 100907)
Recent Studies (post-2010) (mdl 100907)
32371,24165539

Protein Interaction Comparison

ProteinTaxonomynnc 112 (IC50)mdl 100907 (IC50)
5-hydroxytryptamine receptor 2AHomo sapiens (human)0.0048

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bullich, S; Catafau, AM; Farre, M; Gunn, RN; Herance, R; Laruelle, M; Rabiner, EA; Radua, J; Searle, GE1

Other Studies

1 other study(ies) available for nnc 112 and mdl 100907

ArticleYear
Imaging cortical dopamine D1 receptors using [11C]NNC112 and ketanserin blockade of the 5-HT 2A receptors.
    Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism, 2010, Volume: 30, Issue:5

    Topics: Adult; Animals; Benzazepines; Benzofurans; Brain; Carbon Radioisotopes; Humans; Image Interpretation, Computer-Assisted; Ketanserin; Magnetic Resonance Imaging; Male; Positron-Emission Tomography; Receptors, Dopamine D1; Serotonin 5-HT2 Receptor Antagonists; Staining and Labeling; Young Adult

2010